Glutamate and Antipsychotic Treatment Response in Patients with Schizophrenia: a Cross-Sectional Multimodal MRI Study
Not Applicable
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000024392
- Lead Sponsor
- Keio University School of Medicine Department of Neuropsychiatry
- Brief Summary
A total of 95 participants were included (TRS=29, non-TRS=33, and HCs=33). dACCGlx levels were higher in the TRS group versus HCs. No group differences were identified in the caudate. Our results suggest that higher Glx levels in the dACC may reflect the difference indisease category between TRS and non-TRS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
Not translated yet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot translated yet
- Secondary Outcome Measures
Name Time Method ot translated yet